EDITOR-Over the past 10 years, several authors have reported microdeletions in the long arm of the Y chromosome (Yq) in men with idiopathic, non-obstructive azoospermia or severe oligospermia. These microdeletions were clustered on the Yq fragment previously described as the azoospermia factor region (AZF). 1 More recently, a number of genes expressed specifically in the testes and mapping to AZFa, AZFb, or AZFc subregions have been cloned. [2] [3] [4] One of the approaches to understanding the role of these genes in human spermatogenesis is to look for a correlation between the lack of given AZF genes and the particular spermatogenic defect in the phenotypes of the patients. However, attempts to find such a correlation have failed so far. Instead, a broad spectrum of phenotypes ranging clinically from azoospermia to severe oligospermia and histologically from Sertoli cell only syndrome (SCOS) to hypospermatogenesis has been described in association with AZFc deletions. 5 6 A recent study found chromosomal aberrations in 15% of azoospermic patients. 7 However, in papers focusing on the analysis of AZF microdeletions in patients with idiopathic infertility, 2 3 5 8-30 systematic, bilateral, histological, molecular, and cytogenetic analyses in the same large group of patients was rarely carried out, thus limiting information on the coexistence of AZF deletions and chromosomal aberrations.
In this study, we propose and test the hypothesis that chromosomal defects may often accompany AZF deletions and cause the lack of a genotype-phenotype correlation in human male idiopathic infertility. We also attempt to evaluate the nature of the spermatogenetic failure associated with isolated AZFc deletions. For this purpose, we performed a dual genetic analysis of karyotypes and molecular status of the AZF region along with bilateral testicular histological evaluation in 94 patients with non-obstructive, idiopathic infertility and azoospermia, severe oligospermia, or oligospermia.
Material and methods
Sixty five men with azoospermia (lack of sperm cells in semen), 23 men with severe oligospermia (fewer than 5 × 10 6 sperm cells/ml semen), and six with oligospermia (5-10 × 10 6 sperm cells/ml semen), all of them of Polish origin, were included in the study.
Histological analyses of biopsies from both testes of 77 patients were performed in formalin fixed paraYn embedded tissue blocks. Sections were cut at 4 µm thickness and stained with haematoxylin-eosin.
Chromosome studies were carried out on peripheral blood lymphocytes of 93 out of 94 patients using GTG, FPG, CBG, and QFQ banding. Karyotypes were analysed in at least 100 metaphases.
DNA was isolated from 10 ml of peripheral blood leucocytes of the patients and, when available, also from the fathers or other male relatives on the paternal side. For molecular analysis, genomic DNA was amplified by PCR using primers specific for 23 Y chromosome specific sequence tagged site (STS) markers (19 mapping to AZFa, AZFb, and AZFc and four mapping to short arm of the Y chromosome) according to conditions described in the Genebank entry.
Results

HISTOLOGICAL PHENOTYPES
The histological evaluation of testicular biopsies was performed in all 77 patients, 62 with azoospermia, 14 with severe oligospermia, and In four cases (IHG22, IHG67, IHG82, and IHG120), deletions were found to be de novo, and all STS markers absent in the patients were present in their father. DNA samples of close male relatives of patients IHG8 and IHG18 were not available and therefore the de novo status could not be tested.
KARYOTYPING
Patients IHG8, IHG22, and IHG120 were mosaic: They were carrying one cell line 46,XY 
+ presence, − absence of STS. *The presence of CDY2 and the absence of CDY1 was detected by SSCP analysis of PCR product corresponding to the sY638 (data not shown). The sequence difference enables SSCP distinguishing between CDY2 and CDY1 copies. with a large terminal deletion (IHG8 and IHG22) or small interstitial deletion (IHG120) and a second cell line (45,X) lacking the entire Y chromosome ( 
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Evaluation of the interstitial tissue
Discussion
GENOTYPE-PHENOTYPE CORRELATION
Among 94 infertile but otherwise normal males, we describe six with two types of AZF deletions, large and terminal encompassing AZFb/AZFc/heterochromatin (IHG8, IHG22) and small and interstitial encompassing AZFc (IHG18, IHG67, IHG82, IHG120). In confirmation of our hypothesis that the lack of correlation between the size of AZF deletions and the phenotype of infertile men may be caused by coexistence of the AZF deletion with a chromosomal aberration, we found a mosaic 45,X cell line in three of five karyotyped AZF deleted patients (a frequency of at least 50%). Several cases of infertile males with 45,X and 46,XY cell lines with the abnormal Y chromosome were described before molecular studies of male infertility were available. [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] Among these cases, the aberrant Y chromosome was described as being isodicentric, 33 38-41 or a ring chromosome, 31 32 44 45 or just lacking Yq, 1 34-37 40 42 43 as in the two cases, IHG8 and IHG22, described in this study. Most of these previously described infertile males with 45,X mosaic karyotypes and a non-fluorescent Y rarely had a "pure sterility" phenotype, but usually manifested several somatic features, mostly short stature, 35 36 42 43 gynaecomastia, 34 36-38 or genital ambiguity. 42 43 In our study, however, all three patients with a 45,X mosaic cell line had a pure sterility phenotype, which was the case even in those with a high proportion of 45,X (patients IHG8 and IHG22). Another patient of this type was previously published and had 45,X in 50% of blood cells, no somatic abnormalities, and a height of 183 cm. 39 However, that report did not describe the patient's testicular histology, so phenotype-genotype correlation could not be analysed to the extent to which it was possible in our patients.
Pure 45,X chromosomal constitution is known to result in incomplete ovarian development (streak gonads in the adult). Phenotypic variability of these published 45,X mosaic infertile patients, including our patients, is probably the result of the tissue representation of 45,X mosaicism, which may to a varying degree aVect the gonadal development and differentiation processes. 46 Similarly, 45,X mosaicism could enhance the infertility phenotype caused by a coexisting AZF deletion of any size. Since the representation of the 45,X line in the target tissue, that is, primordial germ cells or spermatogonia, may be diVerent from the one observed in blood cells, the phenotype enhancement in AZFdel/45,X subjects cannot be accurately evaluated, making the correlation of the size of the AZF deletion and the infertility phenotype very diYcult. Thus, patient IHG120 with 45,X mosaicism should not be compared to those who have a similar sized deletion and no 45,X cell line in blood (IHG67 and IHG82). Owing to the same limitations, 45,X mosaic patients IGH8 and IGH22 carrying large terminal deletions should not be directly compared to the rest of the patients carrying smaller interstitial deletions.
However, this study does show that AZFc microdeletions alone may result in incomplete maturation arrest in which some secondary spermatocytes and normal appearing spermatogonia are present (IHG67), or even in hypospermatogenesis (IHG82) in which all developmental stages of germ cells are found, although in fewer numbers. We were able to find this despite a broad spectrum of observed phenotypes (tables 1 and 3) and sizes of AZF deletions (table 2) , which were typically associated with AZFc deletions in other studies. 5 6 Detection of such a clear genotype-phenotype correlation in our patients with isolated AZFc microdeletion was possible only when the karyotypic defect was excluded or confirmed in the patients studied and a systematic bilateral histological evaluation accompanied the AZFc deletion molecular screening. Since interphase FISH with Y probes in testicular samples from AZF deleted patients was not performed, we cannot exclude the possibility of a 45,X cell line in the target tissue. However, testicular biopsy is an invasive procedure and therefore is limited to azoospermic patients when obtaining spermatozoa for ICSI in vitro fertilisation.
The association of incomplete maturation arrest phenotype with isolated AZFc deletions found in this study could also indicate that genes encoded by AZFc, for example, DAZ or CDY1, are not crucial for the establishment of the germline stem cells, the spermatogonia.
ORIGIN OF 45,X CELL LINE MOSAICISM WITH AZFc MICRODELETIONS
It was previously reported that Y chromosomes carrying several types of cytogenetically detectable aberrations, including the lack of Yq, have a tendency to be lost in the course of cell division and lead to the appearance of the 45,X mosaic cell line. 47 48 Therefore, it can be assumed that large AZF terminal deletions and the mosaic 45,X cell line in patients IHG8 and IHG22 are not independent events, and that the 45,X line resulted from a loss of the aberrant Yq chromosome.
Interestingly, in patient IHG120, the mosaic 45,X line coexists with an interstitial AZFc microdeletion. This finding seems to indicate that smaller, cytogenetically undetectable molecular defects could predispose to the loss of the entire Y chromosome too. So far, only a single case of that type has been reported, 20 although most papers describing patients screened for AZFc microdeletions did not include cytogenetic analysis, so 45,X mosaicism could not be excluded. Taken together, our data (one patient out of three) and the ones of Oliva et al 20 (one patient out of 10) show that at least 15% of karyotyped patients with AZFc microdeletions do carry a mosaic 45,X cell line. This seems to be less frequent than the coexistence of 45,X with the terminal deletions of Yq (both patient IHG8 and IHG22), but frequent significantly enough to be addressed in future or even retrospective studies.
In conclusion, our results underline the importance of a combined molecular and karyotypic approach as well as thorough histological analysis for proper evaluation of genotype-phenotype correlation in patients with spermatogenic failure carrying AZFc deletions. 
